Category: freely available

Research assistant fired for using student’s thesis in a paper

Reviews in Medical Microbiology

A research assistant at King Saud University (KSU) has lost his job after he used material from a student’s thesis without permission or attribution in a paper.

Lakshmana Krishnappa was terminated after a disciplinary committee considered his case last November, the vice dean for postgraduate training and research at KSU told Retraction Watch. In April of last year, Krishnappa retracted a paper published in January 2015 — we think that’s the date; the journal doesn’t make it all that clear — that included plagiarized material, published in Reviews in Medical Microbiology. He recently lost a second unrelated paper for duplication.

Here’s the retraction notice for the Reviews in Medical Microbiology paper, “Acinetobacter baumannii: pathogenecity, virulence factors and their correlation with adherence and invasion:”

Continue reading Research assistant fired for using student’s thesis in a paper

Does posting on PubPeer count as prior publication? Journal says yes, rejects letter rebutting campus sexual assault data

Jim Hopper

Journals typically shy away from publishing data and text readers have seen before — but amidst the newly established norms of open science and data sharing, what counts as a prior publication?

We’re asking ourselves that question after learning that JAMA Pediatrics has rejected a letter rebutting a recent study in the journal about sexual assault on college campuses after deciding that posting the letter on PubPeer is a prior publication.

The submitted letter (which you can read here) was co-authored by independent consultant, therapist and researcher Jim Hopper, who is also a Teaching Associate in Psychology at Harvard Medical School. It concerned a 2015 paper published in JAMA Pediatrics, which suggested that the long-held belief that most rapists on college campuses are repeat offenders may be false. The findings can have major implications for university efforts to stop assaults, as institutions weigh whether to divert resources towards punishment (if serial offenders are largely responsible) or prevention (if most men only commit assaults once). Continue reading Does posting on PubPeer count as prior publication? Journal says yes, rejects letter rebutting campus sexual assault data

Authors correct highly cited biology paper due to “genuine mistake”

Journal of Cell ScienceAuthors of a highly cited biology paper in the Journal of Cell Science (JCS) have corrected the data underlying one of the figures.

The 2003 paper, “The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors,” has been cited 566 times, according to Thomson Reuters Web of Science. One of the authors is the last author on a recent high profile retraction from Nature Genetics, which cost the first author a grant from the European Molecular Biology Organisation.

The correction note tells us a bit more: Continue reading Authors correct highly cited biology paper due to “genuine mistake”

Retraction count for Shigeaki Kato climbs to 39

Shigeaki Kato
Shigeaki Kato

We’ve found another retraction for Shigeaki Kato, number seven on our leaderboard.

Our count for Kato has now risen to 39; we added five retraction notices to our count for Kato last month. These notices follow an investigation at the University of Tokyo, where Kato used to work, which found 43 papers contained “likely altered or forged materials,” according to a 2013 news article from The Asahi Shimbun.

Here’s the retraction note for “1alpha,25(OH)2D3-induced DNA methylation suppresses the human CYP271B1 gene,” published in Molecular and Cellular Endocrinology:

Continue reading Retraction count for Shigeaki Kato climbs to 39

Economics paper retracted due to “extensive changes”

727710An article has been retracted from a proceedings of an economics conference after the publisher identified errors in several parts of the study.

The retraction follows criticism from a Romanian blogger, who contacted the journal about several issues, and posted communications she received about the paper, “Sustainability of Social Enterprises: A Discourse Analysis.” It was part of a volume of Procedia Economics and Finance from a 2014 conference, “Economic Scientific Research – Theoretical, Empirical and Practical Approaches,” also known as ESPERA 2014.

According to the paper, peer review was

under responsibility of the Scientific Committee of ESPERA 2014.

Apparently, the peer review process missed a few errors. The retraction note explains:

Continue reading Economics paper retracted due to “extensive changes”

Engineer: Paper plagiarized my thesis — badly

GeoScience EngineeringAn engineering journal has published a statement by a researcher alleging that a 2015 paper in the same journal plagiarized his thesis — and was so poorly done it “should not have been published.”

In the “counterstatement” to the 2015 paper, Christian Seip of the Rostock University in Germany said the paper — about the development of a Marine Spatial Data Infrastructure (MSDI) in Croatia — took content from his dissertation thesis, about MSDI geoportals in Germany.

In addition, Seip argued that the original paper, “A Framework for Evaluation of Marine Spatial Data Geoportals Using Case Studies,” in GeoScience Engineering (GSE) — shows “major weaknesses” and therefore “should have not been published even [if] it was not plagiarized.”

Seip told us: Continue reading Engineer: Paper plagiarized my thesis — badly

Author dispute retracts paper suggesting NSAIDs curb growth in rats

jpedorthoThe corresponding author asked the Journal of Pediatric Orthopaedics to retract an article that found popular pain medicines can curb growth in rats, in light of an unresolved authorship dispute.

The article, “Nonsteroidal Anti-Inflammatory Drugs Cause Inhibition of the Growth Plate in Cultured Rat Metatarsal Bones,” details preliminary results that indicate nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce growth in rat bones in a dose-dependent manner, suggesting caution in treating chronic inflammatory diseases in children. The editor told us the paper was “highly rated” by reviewers and the results were “never in question,” but the senior author asked to pull the paper after failing to resolve a dispute with a researcher who asked to be added as an author.

According to the notice:  Continue reading Author dispute retracts paper suggesting NSAIDs curb growth in rats

Authors retract, replace highly cited JAMA Psych paper for “pervasive errors”

JAMA PsychiatryAuthors have retracted a highly cited JAMA Psychiatry study about depression after failing to account for some patient recoveries, among other mistakes.

It’s a somewhat unusual notice — it explains that the paper has been retracted and replaced with a new, corrected version.

The study, which included 452 adults with major depressive disorder, concluded that cognitive therapy plus medication works better to treat depression than pills alone. But after it was published, a reader pointed out that some of the numbers in a table were incorrect. The authors reviewed the data and redid their analysis, and discovered “a number of pervasive errors.”

The notice (termed “notice of retraction and replacement”) explains the consequences of those errors:

Continue reading Authors retract, replace highly cited JAMA Psych paper for “pervasive errors”

Journals retract two heart papers with “nearly identical” abstracts

Screen Shot 2016-02-22 at 4.46.17 PMJournals have retracted two papers after realizing that they contain “nearly identical” abstracts and introductions, published only months apart. 

The two retracted papers, along with a third that also contains similar text, all conclude that a certain polymorphism could signal a risk for coronary artery disease among Chinese people, though each paper presents different data. The papers do not have any authors in common; the first authors are all based at different hospitals in China. The editor in chief of one journal told us that some of the reviewers did not use institutional email addresses, which leaves open the possibility that they were fake emails, and the peer-review process was compromised.

Here’s the first retraction notice, for “Fibroblast growth factor receptor 4 polymorphisms and susceptibility to coronary artery disease,” published in DNA and Cell Biology. The notice states the paper contains:

Continue reading Journals retract two heart papers with “nearly identical” abstracts

Singapore investigation leads to another retraction, correction for Harvard research fellow

Screen Shot 2016-03-25 at 8.12.49 AM

After an investigation found evidence of misconduct, a biologist has issued a third retraction.

Sudarsanareddy Lokireddy — now a research fellow at Harvard Medical School — “admitted falsification,” a Research Integrity Officer at Nanyang Technological University in Singapore told us in December. According to The Scientist, another journal has also published a correction that the authors had requested earlier.

The newly retracted paper is “Myostatin is a novel tumoral factor that induces cancer cachexia,” published in Biochemical Journal and cited 40 times, according to Thomson Reuters Web of Science. Here’s the retraction note: